Human interictal epileptiform discharges are bidirectional traveling waves echoing ictal discharges

  1. Elliot H Smith  Is a corresponding author
  2. Jyun-you Liou
  3. Edward M Merricks
  4. Tyler Davis
  5. Kyle Thomson
  6. Bradley Greger
  7. Paul House
  8. Ronald G Emerson
  9. Robert Goodman
  10. Guy M McKhann
  11. Sameer Sheth
  12. Catherine Schevon
  13. John Rolston  Is a corresponding author
  1. University of Utah, United States
  2. Weill Cornell Medicine, United States
  3. Columbia University Medical Center, United States
  4. Arizona State University, United States
  5. Neurosurgical Associates, LLC, United States
  6. Hospital for Special Surgery, United States
  7. Lenox Hill Hospital, United States
  8. Baylor College of Medicine, United States
  9. Columbia University, United States

Abstract

Interictal epileptiform discharges (IEDs), also known as interictal spikes, are large intermittent electrophysiological events observed between seizures in patients with epilepsy. Though they occur far more often than seizures, IEDs are less studied, and their relationship to seizures remains unclear. To better understand this relationship, we examined multi-day recordings of microelectrode arrays implanted in human epilepsy patients, allowing us to precisely observe the spatiotemporal propagation of IEDs, spontaneous seizures, and how they relate. These recordings showed that the majority of IEDs are traveling waves, traversing the same path as ictal discharges during seizures, and with a fixed direction relative to seizure propagation. Moreover, the majority of IEDs, like ictal discharges, were bidirectional, with one predominant and a second, less frequent antipodal direction. These results reveal a fundamental spatiotemporal similarity between IEDs and ictal discharges. These results also imply that most IEDs arise in brain tissue outside the site of seizure onset and propagate toward it, indicating that the propagation of IEDs provides useful information for localizing the seizure focus.

Data availability

Raw data is available upon establishment of a data use agreement with Columbia University Medical Center as required by their Institutional Review Board (IRB). Data from human subjects was analyzed, from which the dates of implants can potentially be reconstructed. This is especially true for a study like this one, in which chronic recordings were carried out for the full duration of the patients' hospital stays. Sharing these data widely could therefore expose private health information of participants, which is why a data use agreement is required by the IRB. Interested Researchers should contact Dr. Schevon to get the data use agreement process started with the Columbia University Medical Center IRB.Analysis code is upload to GitHub: https://github.com/elliothsmith/IEDs. We have included preprocessed data files for all IEDs, hosted online at OSF: https://osf.io/zhk24/. Data files include LFP, MUA event times, and traveling wave model coefficients for all detected IEDs.

The following data sets were generated

Article and author information

Author details

  1. Elliot H Smith

    Department of Neurolosurgery, University of Utah, Salt Lake City, United States
    For correspondence
    e.h.smith@utah.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4323-4643
  2. Jyun-you Liou

    Department of Anesthesiology, Weill Cornell Medicine, New York, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4851-3676
  3. Edward M Merricks

    Department of Neurology, Columbia University Medical Center, New York CIty, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8172-3152
  4. Tyler Davis

    Department of Neurosurgery, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  5. Kyle Thomson

    Departments of Neurosurgery, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  6. Bradley Greger

    Department of Bioengineering, Arizona State University, Tempe, United States
    Competing interests
    No competing interests declared.
  7. Paul House

    Neurosurgical Associates, LLC, Murray, United States
    Competing interests
    Paul House, is affiliated with Neurosurgical Associates, LLC. The author has no financial interests to declare..
  8. Ronald G Emerson

    Hospital for Special Surgery, New York, United States
    Competing interests
    No competing interests declared.
  9. Robert Goodman

    Lenox Hill Hospital, New York, United States
    Competing interests
    No competing interests declared.
  10. Guy M McKhann

    Department of Neurological Surgery, Columbia University Medical Center, New York, United States
    Competing interests
    Guy M McKhann, reports fees from Koh Young, Inc.
  11. Sameer Sheth

    Department of Neurological Surgery, Baylor College of Medicine, Houston, United States
    Competing interests
    Sameer Sheth, consulting for Boston Scientific, Abbott, Neuropace, Zimmer Biomet..
  12. Catherine Schevon

    Department of Neurology, Columbia University, New York, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4485-7933
  13. John Rolston

    Department of Neurosurgery, University of Utah, Salt Lake City, United States
    For correspondence
    john.rolston@utah.edu
    Competing interests
    John Rolston, reports fees from Medtronic, Inc..

Funding

National Institutes of Health (NINDS R21 NS113031)

  • Elliot H Smith
  • Catherine Schevon
  • John Rolston

National Institutes of Health (NINDS K23 NS114178)

  • John Rolston

National Institutes of Health (S10 OD018211)

  • Catherine Schevon

National Institutes of Health (R01 NS084142)

  • Catherine Schevon

American Epilepsy Society (JIA)

  • Elliot H Smith

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The Institutional Review Boards at the University of Utah (IRB_00114691) and Columbia University Medical Center (IRB- AAAB6324) approved these studies. All participants provided informed consent prior to surgery for implantation of the clinical and research electrodes.

Copyright

© 2022, Smith et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,792
    views
  • 520
    downloads
  • 41
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elliot H Smith
  2. Jyun-you Liou
  3. Edward M Merricks
  4. Tyler Davis
  5. Kyle Thomson
  6. Bradley Greger
  7. Paul House
  8. Ronald G Emerson
  9. Robert Goodman
  10. Guy M McKhann
  11. Sameer Sheth
  12. Catherine Schevon
  13. John Rolston
(2022)
Human interictal epileptiform discharges are bidirectional traveling waves echoing ictal discharges
eLife 11:e73541.
https://doi.org/10.7554/eLife.73541

Share this article

https://doi.org/10.7554/eLife.73541

Further reading

    1. Computational and Systems Biology
    Matthew Millard, David W Franklin, Walter Herzog
    Research Article

    The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Kara Schmidlin, Sam Apodaca ... Kerry Geiler-Samerotte
    Research Article

    There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.